University of Michigan unveils an app for breast cancer patients
Called Breast Cancer Ally, the application was developed after gathering feedback from both specialists who cared for patients and patients themselves.
Voluntis, AstraZeneca to test companion app in ovarian cancer studies
The app will help clinicians and patients manage side effects of hypertension and diarrhoea, which can be associated with therapy with cediranib and olaparib.
MobileODT makes cervical cancer diagnostics mobile
The device and its companion app turn pretty much any smartphone into a portable colposcope, making the screening process available all around the world.
New ResearchKit studies for autism, epilepsy and melanoma unveiled
Apple announced that researchers from Duke University, Johns Hopkins and Oregon Health & Science University are launching new medical studies using ResearchKit.
HÜD turns any smartphone into a dermatoscope
The smart mole scanner, which is designed to be attached to a smartphone's camera, is now live on crowdfunding website Indiegogo.
Roche, Voluntis team-up over a mobile therapy for breast cancer
Said therapy will be evaluated in a clinical trial in France, and will involve an app and telemedicine services to monitor patients between doctor visits.
SkinVision secures $3.4M for its skin cancer checker app
The company will use the funds to widen applications for its technology beyond moles and melanomas, and expand into new geographical markets.
Tweet chats could serve as a motivational tool for patients with breast cancer
Of the 206 respondents to the survey, 93% of whom were women, 63% said they strongly agreed with the safe and welcoming statement, while 24% somewhat agreed.
Cyrcadia enters clinical trials for its wearable breast cancer detection device
After the trial is completed, the company will produce a wearable device (iTBra), which will utilize a comfortable data collection device placed under a bra.
MoleScope turns a smartphone into a skin cancer diagnostic tool
The setup involves a mini-microscope that attaches to a smartphone, an app and a HIPAA-compliant cloud-based analytical platform called DermEngine.